MedTrace Logo

Non-invasive Absolute Intracranial Pressure Measurement in Patients With Malignant Middle Cerebral Artery Infarction for Determination of Timing to Descompressive Craniectomy.

NCT03221959 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2017-07-26

No results posted yet for this study

Summary

This is a single centre, observational study with a medical device which has Conformité Européenne (CE) marking. The aim of the study is to demonstrate that patients with malignant middle cerebral artery infarction (M-MCA) show an increased intra-cranial pressure (ICP) compared to neurological patients without M-MCA infarction or other space-occupying indications.

Conditions

  • Intracranial Pressure Increase

Interventions

DEVICE

Medical Device Vittamed 205

Intracranial pressure measurement

Sponsors & Collaborators

  • Swiss National Fund for Scientific Research

    collaborator OTHER

  • Kienzler Jenny

    lead OTHER

Principal Investigators

  • jenny kienzler · Kantonsspital Aarau

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2020-12-31
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03221959 on ClinicalTrials.gov